25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Amedisys Inc
Buy, Hold or Sell?

Let's analyze Amedisys Inc together

I guess you are interested in Amedisys Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Amedisys Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Amedisys Inc

I send you an email if I find something interesting about Amedisys Inc.

1. Quick Overview

1.1. Quick analysis of Amedisys Inc (30 sec.)










1.2. What can you expect buying and holding a share of Amedisys Inc? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€33.16
Expected worth in 1 year
€34.75
How sure are you?
85.7%

+ What do you gain per year?

Total Gains per Share
€1.59
Return On Investment
1.9%

For what price can you sell your share?

Current Price per Share
€84.00
Expected price per share
€79.00 - €87.00
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Amedisys Inc (5 min.)




Live pricePrice per Share (EOD)
€84.00
Intrinsic Value Per Share
€118.17 - €140.46
Total Value Per Share
€151.33 - €173.62

2.2. Growth of Amedisys Inc (5 min.)




Is Amedisys Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$1.1b$1.1b$73.6m6.3%

How much money is Amedisys Inc making?

Current yearPrevious yearGrowGrow %
Making money$10.8m-$2.4m$13.2m122.5%
Net Profit Margin1.9%-0.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Amedisys Inc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Amedisys Inc?

Welcome investor! Amedisys Inc's management wants to use your money to grow the business. In return you get a share of Amedisys Inc.

First you should know what it really means to hold a share of Amedisys Inc. And how you can make/lose money.

Speculation

The Price per Share of Amedisys Inc is €84.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Amedisys Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Amedisys Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €33.16. Based on the TTM, the Book Value Change Per Share is €0.40 per quarter. Based on the YOY, the Book Value Change Per Share is €0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Amedisys Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.62-0.7%0.330.4%-0.07-0.1%0.510.6%0.510.6%
Usd Book Value Change Per Share-0.65-0.8%0.430.5%0.060.1%2.573.1%2.573.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.65-0.8%0.430.5%0.060.1%2.573.1%2.573.1%
Usd Price Per Share92.27-92.27-87.25-105.37-105.37-
Price to Earnings Ratio-37.10-20.77-20.69-25.37-25.37-
Price-to-Total Gains Ratio-141.38-55.93-66.98-81.52-81.52-
Price to Book Ratio2.56-2.57-2.59-3.21-3.21-
Price-to-Total Gains Ratio-141.38-55.93-66.98-81.52-81.52-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share91.182
Number of shares10
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.432.57
Usd Total Gains Per Share0.432.57
Gains per Quarter (10 shares)4.3125.71
Gains per Year (10 shares)17.23102.86
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10177010393
2034240206196
3052410309299
4069580411402
5086750514505
60103920617608
701211090720711
801381260823814
901551430926917
100172160010291020

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%10.02.00.083.3%12.02.00.085.7%12.02.00.085.7%12.02.00.085.7%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%12.02.00.085.7%12.02.00.085.7%12.02.00.085.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.014.00.0%0.00.014.00.0%0.00.014.00.0%
Total Gains per Share3.01.00.075.0%10.02.00.083.3%12.02.00.085.7%12.02.00.085.7%12.02.00.085.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Amedisys Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.6010.397-252%0.057-1149%2.369-125%2.369-125%
Book Value Per Share--33.16433.078+0%31.123+7%30.811+8%30.811+8%
Current Ratio--1.2291.167+5%1.030+19%1.057+16%1.057+16%
Debt To Asset Ratio--0.4480.446+1%0.4500%0.458-2%0.458-2%
Debt To Equity Ratio--0.8450.842+0%0.862-2%0.891-5%0.891-5%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--1902773001.2001911301126.4750%1790344133.025+6%2315953254.693-18%2315953254.693-18%
Eps---0.5730.304-288%-0.069-88%0.467-223%0.467-223%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--0.8630.884-2%0.869-1%1.116-23%1.116-23%
Free Cash Flow Per Share--1.9381.506+29%0.879+121%1.064+82%1.064+82%
Free Cash Flow To Equity Per Share--1.6231.162+40%0.260+524%1.055+54%1.055+54%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--140.461--------
Intrinsic Value_10Y_min--118.168--------
Intrinsic Value_1Y_max--5.784--------
Intrinsic Value_1Y_min--5.676--------
Intrinsic Value_3Y_max--23.697--------
Intrinsic Value_3Y_min--22.496--------
Intrinsic Value_5Y_max--49.229--------
Intrinsic Value_5Y_min--45.149--------
Market Cap--2785972580.0002782554353.375+0%2621621655.625+6%3164383323.893-12%3164383323.893-12%
Net Profit Margin---0.0340.019-283%-0.005-86%0.029-216%0.029-216%
Operating Margin----0%-0%-0%-0%
Operating Ratio--1.4991.477+1%1.470+2%1.476+2%1.476+2%
Pb Ratio2.533-1%2.5632.5700%2.588-1%3.207-20%3.207-20%
Pe Ratio-36.660+1%-37.09720.772-279%20.685-279%25.371-246%25.371-246%
Price Per Share84.000-1%85.00085.0000%80.375+6%97.071-12%97.071-12%
Price To Free Cash Flow Ratio10.834-1%10.963-11.429+204%-4.695+143%20.865-47%20.865-47%
Price To Total Gains Ratio-139.718+1%-141.38255.933-353%66.977-311%81.520-273%81.520-273%
Quick Ratio--0.5760.670-14%0.695-17%0.710-19%0.710-19%
Return On Assets---0.0100.005-286%-0.001-86%0.008-214%0.008-214%
Return On Equity---0.0180.010-286%-0.003-82%0.016-209%0.016-209%
Total Gains Per Share---0.6010.397-252%0.057-1149%2.369-125%2.369-125%
Usd Book Value--1179920869.3091175442036.824+0%1101810290.754+7%1090695206.474+8%1090695206.474+8%
Usd Book Value Change Per Share---0.6530.431-252%0.062-1149%2.571-125%2.571-125%
Usd Book Value Per Share--35.99935.906+0%33.784+7%33.446+8%33.446+8%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--2065460092.8032074717372.7890%1943418556.399+6%2513967257.969-18%2513967257.969-18%
Usd Eps---0.6220.330-288%-0.075-88%0.507-223%0.507-223%
Usd Free Cash Flow--68960420.78453570996.370+29%31117586.159+122%37712160.941+83%37712160.941+83%
Usd Free Cash Flow Per Share--2.1041.635+29%0.954+121%1.155+82%1.155+82%
Usd Free Cash Flow To Equity Per Share--1.7621.262+40%0.282+524%1.145+54%1.145+54%
Usd Market Cap--3024173235.5903020462750.589+0%2845770307.181+6%3434938098.086-12%3434938098.086-12%
Usd Price Per Share91.182-1%92.26892.2680%87.247+6%105.371-12%105.371-12%
Usd Profit---20380237.75110807345.790-289%-2436658.866-88%16509811.081-223%16509811.081-223%
Usd Revenue--598029632.855587059043.171+2%559074589.828+7%565743626.111+6%565743626.111+6%
Usd Total Gains Per Share---0.6530.431-252%0.062-1149%2.571-125%2.571-125%
 EOD+4 -2MRQTTM+14 -19YOY+19 -165Y+16 -1910Y+16 -19

3.3 Fundamental Score

Let's check the fundamental score of Amedisys Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-36.660
Price to Book Ratio (EOD)Between0-12.533
Net Profit Margin (MRQ)Greater than0-0.034
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.576
Current Ratio (MRQ)Greater than11.229
Debt to Asset Ratio (MRQ)Less than10.448
Debt to Equity Ratio (MRQ)Less than10.845
Return on Equity (MRQ)Greater than0.15-0.018
Return on Assets (MRQ)Greater than0.05-0.010
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Amedisys Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose84.000
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Amedisys Inc

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Amedisys Inc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Amedisys Inc to the  industry mean.
  • A Net Profit Margin of -3.4% means that €-0.03 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Amedisys Inc:

  • The MRQ is -3.4%. The company is making a loss. -1
  • The TTM is 1.9%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ-3.4%TTM1.9%-5.3%
TTM1.9%YOY-0.5%+2.3%
TTM1.9%5Y2.9%-1.1%
5Y2.9%10Y2.9%0.0%
4.3.1.2. Return on Assets

Shows how efficient Amedisys Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Amedisys Inc to the  industry mean.
  • -1.0% Return on Assets means that Amedisys Inc generated €-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Amedisys Inc:

  • The MRQ is -1.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 0.5%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-1.0%TTM0.5%-1.5%
TTM0.5%YOY-0.1%+0.6%
TTM0.5%5Y0.8%-0.3%
5Y0.8%10Y0.8%0.0%
4.3.1.3. Return on Equity

Shows how efficient Amedisys Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Amedisys Inc to the  industry mean.
  • -1.8% Return on Equity means Amedisys Inc generated €-0.02 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Amedisys Inc:

  • The MRQ is -1.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is 1.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-1.8%TTM1.0%-2.8%
TTM1.0%YOY-0.3%+1.3%
TTM1.0%5Y1.6%-0.7%
5Y1.6%10Y1.6%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Amedisys Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Amedisys Inc is operating .

  • Measures how much profit Amedisys Inc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Amedisys Inc to the  industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Amedisys Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
4.3.2.2. Operating Ratio

Measures how efficient Amedisys Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.50 means that the operating costs are €1.50 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Amedisys Inc:

  • The MRQ is 1.499. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.477. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.499TTM1.477+0.022
TTM1.477YOY1.470+0.007
TTM1.4775Y1.476+0.001
5Y1.47610Y1.4760.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Amedisys Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Amedisys Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 1.23 means the company has €1.23 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Amedisys Inc:

  • The MRQ is 1.229. The company is just able to pay all its short-term debts.
  • The TTM is 1.167. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.229TTM1.167+0.062
TTM1.167YOY1.030+0.137
TTM1.1675Y1.057+0.109
5Y1.05710Y1.0570.000
4.4.3.2. Quick Ratio

Measures if Amedisys Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Amedisys Inc to the  industry mean.
  • A Quick Ratio of 0.58 means the company can pay off €0.58 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Amedisys Inc:

  • The MRQ is 0.576. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.670. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.576TTM0.670-0.094
TTM0.670YOY0.695-0.025
TTM0.6705Y0.710-0.040
5Y0.71010Y0.7100.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Amedisys Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Amedisys Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Amedisys Inc to industry mean.
  • A Debt to Asset Ratio of 0.45 means that Amedisys Inc assets are financed with 44.8% credit (debt) and the remaining percentage (100% - 44.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Amedisys Inc:

  • The MRQ is 0.448. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.446. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.448TTM0.446+0.002
TTM0.446YOY0.450-0.004
TTM0.4465Y0.458-0.012
5Y0.45810Y0.4580.000
4.5.4.2. Debt to Equity Ratio

Measures if Amedisys Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Amedisys Inc to the  industry mean.
  • A Debt to Equity ratio of 84.5% means that company has €0.85 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Amedisys Inc:

  • The MRQ is 0.845. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.842. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.845TTM0.842+0.003
TTM0.842YOY0.862-0.020
TTM0.8425Y0.891-0.049
5Y0.89110Y0.8910.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Amedisys Inc generates.

  • Above 15 is considered overpriced but always compare Amedisys Inc to the  industry mean.
  • A PE ratio of -37.10 means the investor is paying €-37.10 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Amedisys Inc:

  • The EOD is -36.660. Based on the earnings, the company is expensive. -2
  • The MRQ is -37.097. Based on the earnings, the company is expensive. -2
  • The TTM is 20.772. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD-36.660MRQ-37.097+0.436
MRQ-37.097TTM20.772-57.869
TTM20.772YOY20.685+0.087
TTM20.7725Y25.371-4.599
5Y25.37110Y25.3710.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Amedisys Inc:

  • The EOD is 10.834. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 10.963. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -11.429. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD10.834MRQ10.963-0.129
MRQ10.963TTM-11.429+22.393
TTM-11.429YOY-4.695-6.734
TTM-11.4295Y20.865-32.294
5Y20.86510Y20.8650.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Amedisys Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 2.56 means the investor is paying €2.56 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Amedisys Inc:

  • The EOD is 2.533. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.563. Based on the equity, the company is underpriced. +1
  • The TTM is 2.570. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.533MRQ2.563-0.030
MRQ2.563TTM2.570-0.007
TTM2.570YOY2.588-0.018
TTM2.5705Y3.207-0.637
5Y3.20710Y3.2070.000
4.6.2. Total Gains per Share

2.4. Latest News of Amedisys Inc

Does Amedisys Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Amedisys Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-02-27
03:00
Amedisys (AMED) Reports Q4 Earnings: What Key Metrics Have to SayRead
2025-02-26
23:50
Amedisys (AMED) Lags Q4 Earnings and Revenue EstimatesRead
2025-02-26
22:55
Amedisys: Q4 Earnings SnapshotRead
2025-02-26
22:30
Amedisys Reports Fourth Quarter and Year End 2024 Financial ResultsRead
2025-02-21
23:12
DOJ Investigates Medicare Billing Practices at UnitedHealthRead
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-12-312024-03-312024-06-302024-09-302024-12-31
Income before Tax  26,897-1,81625,08220,26945,351-18,64826,703-44,416-17,713
Net Income  17,799-4,53413,26516,49029,756-14,17715,578-34,353-18,775
Net Income from Continuing Operations  17,521-4,07713,44416,56230,006-14,79415,213-38,721-23,508



6.2. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets2,138,714
Total Liabilities958,749
Total Stockholder Equity1,134,541
 As reported
Total Liabilities 958,749
Total Stockholder Equity+ 1,134,541
Total Assets = 2,138,714

Assets

Total Assets2,138,714
Total Current Assets632,083
Long-term Assets1,506,643
Total Current Assets
Cash And Cash Equivalents 303,242
Net Receivables 296,075
Other Current Assets 7,694
Total Current Assets  (as reported)632,083
Total Current Assets  (calculated)607,011
+/- 25,072
Long-term Assets
Property Plant Equipment 123,600
Goodwill 1,213,888
Long Term Investments 69,800
Intangible Assets 81,155
Long-term Assets Other 1,900
Long-term Assets  (as reported)1,506,643
Long-term Assets  (calculated)1,490,343
+/- 16,300

Liabilities & Shareholders' Equity

Total Current Liabilities514,392
Long-term Liabilities444,357
Total Stockholder Equity1,134,541
Total Current Liabilities
Short Long Term Debt 37,968
Accounts payable 39,956
Other Current Liabilities 105,964
Total Current Liabilities  (as reported)514,392
Total Current Liabilities  (calculated)183,888
+/- 330,504
Long-term Liabilities
Long term Debt 339,313
Capital Lease Obligations Min Short Term Debt82,020
Long-term Liabilities Other 182
Long-term Liabilities  (as reported)444,357
Long-term Liabilities  (calculated)421,515
+/- 22,842
Total Stockholder Equity
Retained Earnings 791,156
Total Stockholder Equity (as reported)1,134,541
Total Stockholder Equity (calculated)791,156
+/- 343,385
Other
Capital Stock38
Common Stock Shares Outstanding 32,776
Net Debt 74,039
Net Invested Capital 1,511,822
Net Working Capital 117,691
Property Plant and Equipment Gross 246,400



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-30
> Total Assets 
1,937,645
1,856,968
1,908,392
2,000,986
1,982,127
1,976,245
1,946,959
1,982,402
2,027,417
2,060,170
2,089,871
2,117,368
2,139,114
2,138,714
2,138,7142,139,1142,117,3682,089,8712,060,1702,027,4171,982,4021,946,9591,976,2451,982,1272,000,9861,908,3921,856,9681,937,645
   > Total Current Assets 
432,882
356,684
392,485
394,869
388,780
388,961
405,557
426,544
467,227
496,935
526,448
555,902
579,947
632,083
632,083579,947555,902526,448496,935467,227426,544405,557388,961388,780394,869392,485356,684432,882
       Cash And Cash Equivalents 
124,458
42,694
67,834
26,566
17,956
40,540
49,436
95,377
78,112
126,450
108,234
149,883
245,450
303,242
303,242245,450149,883108,234126,45078,11295,37749,43640,54017,95626,56667,83442,694124,458
       Net Receivables 
274,570
274,961
293,579
305,413
302,470
296,785
294,122
278,785
319,580
313,373
359,359
356,909
301,050
296,075
296,075301,050356,909359,359313,373319,580278,785294,122296,785302,470305,413293,579274,961274,570
       Other Current Assets 
14,024
5,598
10,776
25,493
37,839
6,415
23,581
22,824
33,097
8,260
26,053
26,125
12,962
7,694
7,69412,96226,12526,0538,26033,09722,82423,5816,41537,83925,49310,7765,59814,024
   > Long-term Assets 
1,504,763
1,500,226
1,515,907
1,606,117
1,593,347
1,603,248
1,541,402
1,555,858
1,560,190
1,563,193
1,563,423
1,561,466
1,559,167
1,506,643
1,506,6431,559,1671,561,4661,563,4231,563,1931,560,1901,555,8581,541,4021,603,2481,593,3471,606,1171,515,9071,500,2261,504,763
       Property Plant Equipment 
0
0
0
0
123,091
134,882
118,564
121,541
127,465
130,739
131,109
129,346
127,110
123,600
123,600127,110129,346131,109130,739127,465121,541118,564134,882123,0910000
       Goodwill 
1,188,054
1,196,090
1,204,638
1,289,672
1,285,455
1,287,399
1,244,679
1,244,679
1,244,679
1,244,679
1,244,679
1,244,679
1,244,679
1,213,888
1,213,8881,244,6791,244,6791,244,6791,244,6791,244,6791,244,6791,244,6791,287,3991,285,4551,289,6721,204,6381,196,0901,188,054
       Long Term Investments 
0
53,100
0
0
0
60,500
0
0
0
66,100
0
0
0
69,800
69,80000066,10000060,50000053,1000
       Intangible Assets 
118,084
111,190
106,534
106,189
103,678
101,167
99,929
104,744
103,634
102,675
101,778
100,832
99,698
81,155
81,15599,698100,832101,778102,675103,634104,74499,929101,167103,678106,189106,534111,190118,084
       Long-term Assets Other 
68,105
4,000
84,639
84,686
81,123
3,500
78,230
84,894
84,412
2,700
85,857
86,609
87,680
1,900
1,90087,68086,60985,8572,70084,41284,89478,2303,50081,12384,68684,6394,00068,105
> Total Liabilities 
988,844
880,645
887,740
961,991
912,517
869,672
813,611
921,645
933,899
940,387
947,217
938,482
938,675
958,749
958,749938,675938,482947,217940,387933,899921,645813,611869,672912,517961,991887,740880,645988,844
   > Total Current Liabilities 
454,349
374,282
380,154
427,372
367,200
355,529
353,050
462,401
468,119
473,721
484,860
479,976
486,021
514,392
514,392486,021479,976484,860473,721468,119462,401353,050355,529367,200427,372380,154374,282454,349
       Short Long Term Debt 
13,225
12,995
12,309
12,521
12,628
15,496
26,958
31,465
35,364
36,314
37,232
37,747
37,478
37,968
37,96837,47837,74737,23236,31435,36431,46526,95815,49612,62812,52112,30912,99513,225
       Accounts payable 
41,649
38,217
36,621
43,509
45,527
43,735
40,017
38,557
34,555
28,237
36,249
26,626
32,117
39,956
39,95632,11726,62636,24928,23734,55538,55740,01743,73545,52743,50936,62138,21741,649
       Other Current Liabilities 
0
-3,364
0
0
0
-9,010
0
0
106,000
106,049
106,000
106,000
106,000
105,964
105,964106,000106,000106,000106,049106,00000-9,010000-3,3640
   > Long-term Liabilities 
534,495
506,363
507,586
534,619
545,317
514,143
460,561
459,244
465,780
466,666
462,357
458,506
452,654
444,357
444,357452,654458,506462,357466,666465,780459,244460,561514,143545,317534,619507,586506,363534,495
       Long term Debt 
434,781
432,075
429,453
442,413
443,431
419,420
373,202
369,896
366,853
361,862
356,080
351,442
344,428
339,313
339,313344,428351,442356,080361,862366,853369,896373,202419,420443,431442,413429,453432,075434,781
       Capital Lease Obligations Min Short Term Debt
99,276
100,542
102,196
106,654
105,902
103,025
85,279
85,420
87,989
89,037
88,504
85,454
85,764
82,020
82,02085,76485,45488,50489,03787,98985,42085,279103,025105,902106,654102,196100,54299,276
       Long-term Liabilities Other 
31,991
3,979
4,923
13,408
13,873
4,208
4,781
1,629
1,651
818
828
845
886
182
1828868458288181,6511,6294,7814,20813,87313,4084,9233,97931,991
> Total Stockholder Equity
905,264
931,351
966,758
985,646
1,015,739
1,051,573
1,079,117
1,006,782
1,039,908
1,066,514
1,088,183
1,125,204
1,147,764
1,134,541
1,134,5411,147,7641,125,2041,088,1831,066,5141,039,9081,006,7821,079,1171,051,5731,015,739985,646966,758931,351905,264
   Common Stock00000000000000
   Retained Earnings 
605,016
639,063
670,734
700,313
725,955
757,672
782,918
702,643
728,603
747,925
762,325
794,626
811,537
791,156
791,156811,537794,626762,325747,925728,603702,643782,918757,672725,955700,313670,734639,063605,016
   Capital Surplus 00000000000000
   Treasury Stock00000000000000
   Other Stockholders Equity 00000000000000



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue2,348,324
Cost of Revenue-1,330,647
Gross Profit1,017,6771,017,677
 
Operating Income (+$)
Gross Profit1,017,677
Operating Expense-2,138,757
Operating Income209,567-1,121,080
 
Operating Expense (+$)
Research Development0
Selling General Administrative790,113
Selling And Marketing Expenses0
Operating Expense2,138,757790,113
 
Net Interest Income (+$)
Interest Income8,110
Interest Expense-30,764
Other Finance Cost-0
Net Interest Income-22,654
 
Pretax Income (+$)
Operating Income209,567
Net Interest Income-22,654
Other Non-Operating Income Expenses0
Income Before Tax (EBT)86,216310,264
EBIT - interestExpense = -30,764
43,231
73,995
Interest Expense30,764
Earnings Before Interest and Taxes (EBIT)0116,980
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax86,216
Tax Provision-48,054
Net Income From Continuing Ops38,16238,162
Net Income43,231
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net-100,69722,654
 

Technical Analysis of Amedisys Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Amedisys Inc. The general trend of Amedisys Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Amedisys Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Amedisys Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 84.50 < 87.00 < 87.00.

The bearish price targets are: 79.50 > 79.50 > 79.00.

Tweet this
Amedisys Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Amedisys Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Amedisys Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Amedisys Inc.

Amedisys Inc Daily Moving Average Convergence/Divergence (MACD) ChartAmedisys Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Amedisys Inc. The current adx is .

Amedisys Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Amedisys Inc.

Amedisys Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Amedisys Inc.

Amedisys Inc Daily Relative Strength Index (RSI) ChartAmedisys Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Amedisys Inc.

Amedisys Inc Daily Stochastic Oscillator ChartAmedisys Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Amedisys Inc.

Amedisys Inc Daily Commodity Channel Index (CCI) ChartAmedisys Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Amedisys Inc.

Amedisys Inc Daily Chande Momentum Oscillator (CMO) ChartAmedisys Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Amedisys Inc.

Amedisys Inc Daily Williams %R ChartAmedisys Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Amedisys Inc.

Amedisys Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Amedisys Inc.

Amedisys Inc Daily Average True Range (ATR) ChartAmedisys Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Amedisys Inc.

Amedisys Inc Daily On-Balance Volume (OBV) ChartAmedisys Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Amedisys Inc.

Amedisys Inc Daily Money Flow Index (MFI) ChartAmedisys Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Amedisys Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-10-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-07ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-02STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-10STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-20ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-31WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-02-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-21ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-24STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-11BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Amedisys Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Amedisys Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose84.000
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Amedisys Inc with someone you think should read this too:
  • Are you bullish or bearish on Amedisys Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Amedisys Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Amedisys Inc

I send you an email if I find something interesting about Amedisys Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Amedisys Inc.

Receive notifications about Amedisys Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.